1887

Chapter 101 : Primary Antibody Deficiency Diseases

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Primary Antibody Deficiency Diseases, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815905/9781555813642_Chap101-1.gif /docserver/preview/fulltext/10.1128/9781555815905/9781555813642_Chap101-2.gif

Abstract:

In recent years several rare autosomal recessive disorders that result in antibody deficiency have been reported. Some antibody deficiencies are part of a more broadly expressed systemic disorder or part of an immunodeficiency that affects T cells and/or NK cells as well as B cells. The possibility of immunodeficiency should be considered in any patient who is hospitalized for a major infection requiring intravenous therapy. Most patients with X-linked agammaglobulinemia (XLA) develop recurrent or persistent infections in the first 4 to 8 months of life, and the majority are recognized to have immunodeficiency at less than 3 years of age. Defects in μ heavy chain account for about one-third of the patients with autosomal recessive agammaglobulinemia. Mutation detection is the most practical way of making a definitive diagnosis. Single gene defects of the immune system may have features in common with common variable immunodeficiency (CVID). Recent studies suggest that analysis of B-cell phenotype may be useful in identifying patients with CVID who have more severe disease. Either whole blood or density gradient-separated mononuclear cells can be used to examine lymphocyte cell surface markers. A variety of techniques can be used to provide mutation detection. The advantages and disadvantages of some techniques are listed in this chapter. A detailed history of past infections, a careful family history, and a physical examination that focuses on sites typically involved in antibody deficiencies should come before any laboratory tests.

Citation: Conley M. 2006. Primary Antibody Deficiency Diseases, p 906-913. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch101

Key Concept Ranking

Memory B Cell
0.4838148
Lower Respiratory Tract Infections
0.46771988
Upper Respiratory Tract Infections
0.45031556
B Cells
0.40716252
0.4838148
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Fluorescence-activated cell sorter analysis of B cells from a patient with XLA. Density gradient-separated peripheral blood mononuclear cells from a control (top panels) and a patient with XLA (bottom panels) were stained with PE-CD19 and either FITC-CD3 (left panels) or FITC-polyclonal antihuman IgM (right panels). The dot plot shows approximately 20,000 gated events from the control sample and 200,000 events from the patient sample. The control sample contains 7.3% CD19+ cells, and the patient sample contains 0.07% CD19+ cells. Note that the intensity of CD19 staining is homogeneous in the control sample but variable in the patient sample. Additionally, the majority of the B cells from the patient are very brightly stained for surface IgM, whereas those from the control are variable in surface IgM expression.

Citation: Conley M. 2006. Primary Antibody Deficiency Diseases, p 906-913. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch101
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

SSCP analysis of DNA from a patient with XLA and his family members. Exon 17 of Btk was amplified using primers that flank the coding sequence and splice sites. The PCR products were denatured in heat and then allowed to rena-ture as they migrated through an electrophoresis gel. Lanes 1, 2, 6, and 7 contain DNA from controls. The DNA sample in lane 5 is from a patient with XLA. DNA samples from the patient’s mother and sister are in lanes 3 and 4, respectively.

Citation: Conley M. 2006. Primary Antibody Deficiency Diseases, p 906-913. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch101
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555815905.ch101
1. Adderson, E. E.,, D. H. Viskochil,, J. C. Carey,, A. O. Shigeoka,, J. C. Christenson,, J. F. Bohnsack, and , H. R. Hill. 2000. Growth failure, intracranial calcifications, acquired pancytopenia, and unusual humoral immunodeficiency: a genetic syndrome? Am. J. Med. Genet. 95:1720.
2. Brouet, J. C.,, A. Chedeville,, J. P. Fermand, and , B. Royer. 2000. Study of the B-cell memory compartment in common variable immunodeficiency. Eur. J. Immunol. 30:25162520.
3. Conley, M. E. 1985. B cells in patients with X-linked agam-maglobulinemia. J. Immunol. 134:30703074.
4. Conley, M. E.,, A. Broides,, V. Hernandez-Trujillo,, V. Howard,, H. Kanegane,, T. Miyawaki, and , S. A. Shurtleff. 2005. Genetic analysis of patients with defects in early B-cell development. Immunol. Rev. 203:216234.
5. Conley, M. E., and , V. Howard. 2002. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia. J. Pediatr. 141:566571.
6. Conley, M. E.,, D. Mathias,, J. Treadaway,, Y. Minegishi, and , J. Rohrer. 1998. Mutations in Btk in patients with presumed X-linked agammaglobulinemia. Am. J. Hum. Genet. 62:10341043.
7. Cunningham-Rundles, C., and , C. Bodian. 1999. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin. Immunol. 92:3448.
8. Doffinger, R.,, A. Smahi,, C. Bessia,, F. Geissmann,, J. Feinberg,, A. Durandy,, C. Bodemer,, S. Kenwrick,, S. Dupuis-Girod,, S. Blanche,, P. Wood,, S. H. Rabia,, D. J. Headon,, P. A. Overbeek,, F. Le Deist,, S. M. Holland,, K. Belani,, D. S. Kumararatne,, A. Fischer,, R. Shapiro,, M. E. Conley,, E. Reimund,, H. Kalhoff,, M. Abinun,, A. Munnich,, A. Israel,, G. Courtois, and , J. L. Casanova. 2001. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat. Genet. 27:277285.
9. Ferrari, S.,, S. Giliani,, A. Insalaco,, A. Al Ghonaium,, A. R. Soresina,, M. Loubser,, M. A. Avanzini,, M. Marconi,, R. Badolato,, A. G. Ugazio,, Y. Levy,, N. Catalan,, A. Durandy,, A. Tbakhi,, L. D. Notarangelo, and , A. Plebani. 2001. Mutations of CD40 gene cause an auto-somal recessive form of immunodeficiency with hyper IgM. Proc. Natl. Acad. Sci. USA 98:1261412619.
10. Furr, P. M.,, D. Taylor-Robinson, and , A. D. Webster. 1994. Mycoplasmas and ureaplasmas in patients with hypogammaglobulinaemia and their role in arthritis: microbiological observations over twenty years. Ann. Rheum. Dis. 53:183187.
11. Futatani, T.,, T. Miyawaki,, S. Tsukada,, S. Hashimoto,, T. Kunikata,, S. Arai,, M. Kurimoto,, Y Niida,, H Matsuoka,, Y Sakiyama,, T. Iwata,, S. Tsuchiya,, O. Tatsuzawa,, K. Yoshizaki, and , T. Kishimoto. 1998. Deficient expression of Bruton’s tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood 91:595602.
12. Grimbacher, B.,, A. Hutloff,, M. Schlesier,, E. Glocker,, K. Warnatz,, R. Drager,, H. Eibel,, B. Fischer,, A. A. Schaffer,, H. W. Mages,, R. A. Kroczek, and , H. H. Peter. 2003. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat. Immunol. 4:261268.
13. Hayward, A. R.,, J. Levy,, F. Facchetti,, L. Notarangelo,, H. D. Ochs,, A. Etzioni,, J. Y. Bonnefoy,, M. Cosyns, and , A. Weinberg. 1997. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J. Immunol. 158:977983.
14. Imai, K.,, G. Slupphaug,, W I. Lee,, P. Revy,, S. Nonoyama,, N. Catalan,, L. Yel,, M. Forveille,, B. Kavli,, H. E. Krokan,, H. D. Ochs,, A. Fischer, and , A. Durandy. 2003. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat. Immunol. 4:10231028.
15. Jacquot, S.,, L. Macon-Lemaitre,, F. Paris,, T. Kobata,, Y. Tanaka,, C. Morimoto,, S. E. Schlossman, and , F. Tron. 2001. B-cell co-receptors regulating T cell-dependent antibody production in common variable immunodeficiency: CD27 pathway defects identify subsets of severely immunocompromised patients. Int. Immunol. 13:871876.
16. Lee, W. I.,, T. R. Torgerson,, M. J. Schumacher,, L. Yel,, Q. Zhu, and , H. D. Ochs. 2005. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood 105:18811890.
17. LoGalbo, P. R.,, H. A. Sampson, and , R. H. Buckley. 1982. Symptomatic giardiasis in three patients with X-linked agammaglobulinemia. J. Pediatr. 101:7880.
18. Lopez, G. E.,, A. S. Porpiglia,, M. B. Hogan,, N. Matamoros,, S. Krasovec,, C. Pignata,, C. I. Smith,, L. Hammarstrom,, J. Bjorkander,, B. H. Belohradsky,, G E Casariego,, M. C. Garcia Rodriguez, and , M. E. Conley. 2002. Clinical and molecular analysis of patients with defects in mu heavy chain gene. J. Clin. Investig. 110:10291035.
19. McKinney, R. E., Jr.,, S. L. Katz, and , C. M. Wilfert. 1987. Chronic enteroviral meningoencephalitis in agammaglobu-linemic patients. Rev. Infect. Dis. 9:334356.
20. Minegishi, Y.,, E. Coustan-Smith,, L. Rapalus,, F. Ersoy,, D. Campana, and , M. E. Conley. 1999. Mutations in Iga (CD79a) result in a complete block in B cell development. J. Clin. Investig. 104:11151121.
21. Minegishi, Y.,, E. Coustan-Smith,, Y.-H. Wang,, M. D. Cooper,, D. Campana, and , M. E. Conley. 1998. Mutations in the human A.5/14.1 gene result in B-cell deficiency and agammaglobulinemia. J. Exp. Med. 187:7177.
22. Minegishi, Y.,, A. Lavoie,, C. Cunningham-Rundles,, P. M. Bedard,, J. Hebert,, L. Cote,, K. Dan,, D. Sedlak,, R. H. Buckley,, A. Fischer,, A. Durandy, and , M. E. Conley. 2000. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin. Immunol. 97:203210.
23. Minegishi, Y.,, J. Rohrer,, E. Coustan-Smith,, H. M. Lederman,, R. Pappu,, D. Campana,, A. C. Chan, and , M. E. Conley. 1999. An essential role for BLNK in human B cell development. Science 286:19541957.
24. Noordzij, J. G.,, S. Bruin-Versteeg,, W. M. Comans-Bitter,, N. G. Hartwig,, R. W. Hendriks,, R. de Groot, and , J. J. van Dongen. 2002. Composition of precursor B-cell compartment in bone marrow from patients with X-linked agammaglobulinemia compared with healthy children. Pediatr. Res. 51:159168.
25. Nowak-Wegrzyn, A.,, T. O. Crawford,, J. A. Winkelstein,, K. A. Carson, and , H. M. Lederman. 2004. Immunodeficiency and infections in ataxia-telangiectasia. J. Pediatr. 144:505511.
26. Orita, M.,, Y. Suzuki,, T. Sekiya, and , K. Hayashi. 1989. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874879.
27. Piqueras, B.,, C. Lavenu-Bombled,, L. Galicier,, F. Bergeron-van der Cruyssen,, L. Mouthon,, S. Chevret,, P. Debre,, C. Schmitt, and , E. Oksenhendler. 2003. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J. Clin. Immunol. 23:385400.
28. Plebani, A.,, A. Soresina,, R. Rondelli,, G. Amato,, C. Azzari,, F. Cardinale,, G. Cazzola,, R. Consolini,, D. De Mattia,, G. Dell’Erba,, M. Duse,, M. Fiorini,, S. Martino,, B. Martire,, M. Masi,, V. Monafo,, V. Moschese,, L. Notarangelo,, P. Orlandi,, P. Panei,, A. Pession,, M. Pietrogrande,, C. Pignata,, I. Quinti,, V. Ragno,, P. Rossi,, A. Sciotto,, A. Stabile,, A. Ugazio, and the Italian Pediatric Group for XLA-AIEOP 2002. Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clin. Immunol. 104:221230.
29. Rawlings, D. J. 1999. Bruton’s tyrosine kinase controls a sustained calcium signal essential for B lineage development and function. Clin. Immunol. 91:243253.
30. Revy, P.,, M. Busslinger,, K. Tashiro,, F. Arenzana,, P. Pillet,, A. Fischer, and , A. Durandy. 2000. A syndrome involving intrauterine growth retardation, microcephaly, cerebellar hypoplasia, B lymphocyte deficiency, and progressive pancytopenia. Pediatrics 105:E39.
31. Revy, P.,, T. Muto,, Y. Levy,, F. Geissmann,, A. Plebani,, O. Sanal,, N. Catalan,, M. Forveille,, R. Dufourcq-Lagelouse,, A. Gennery,, I. Tezcan,, F. Ersoy,, H. Kayserili,, A. Ugazio,, N. Brousse,, M. Muramatsu,, L. Notarangelo,, K. Kinoshita,, T. Honjo,, A. Fischer, and , A. Durandy. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 102:565575.
32. Sheffield, V. C.,, J. S. Beck,, A. E. Kwitek,, D. W. Sandstrom, and , E. M. Stone. 1993. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 16:325332.
33. Srivannaboon, K.,, M. E. Conley,, E. Coustan-Smith, and , W. C. Wang. 2001. Hypogammaglobulinemia and reduced numbers of B cells in children with myelodysplastic syndrome. J. Pediatr. Hematol. Oncol. 23:122125.
34. Tsukada, S.,, D. C. Saffran,, D. J. Rawlings,, O. Parolini,, R. C. Allen,, I. Klisak,, R. S. Sparkes,, H. Kubagawa,, T. Mohandas,, S. Quan,, J. W. Belmont,, M. D. Cooper,, M. E. Conley, and , O. N. Witte. 1993. Deficient expression of a B-cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72:279290.
35. Verloes, A.,, M. F. Dresse,, H. Keutgen,, C. Asplund, and , C. I. Smith. 2001. Microphthalmia, facial anomalies, microcephaly, thumb and hallux hypoplasia, and agammaglobulinemia. Am. J. Med. Genet. 101:209212.
36. Warnatz, K.,, A. Denz,, R. Drager,, M. Braun,, C. Groth,, G. Wolff-Vorbeck,, H. Eibel,, M. Schlesier, and , H. H. Peter. 2002. Severe deficiency of switched memory B-cells (CD27(+)IgM(—)IgD(—)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99:15441551.
37. Winkelstein, J. A.,, M. C. Marino,, H. Ochs,, R. Fuleihan,, P. R. Scholl,, R. Geha,, E. R. Stiehm, and , M. E. Conley. 2003. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 82:373384.

Tables

Generic image for table

Citation: Conley M. 2006. Primary Antibody Deficiency Diseases, p 906-913. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch101
Generic image for table

Citation: Conley M. 2006. Primary Antibody Deficiency Diseases, p 906-913. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch101

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error